The Prevalence of Prediabetes in Primary Care Medicine in Tunisia
ConditionPrediabetes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDacima Consulting
About this trial
The study is national, observational and cross-sectional and aims to estimate the prevalence of prediabetes in primary care in Tunisia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ambulatory patient consulting in primary care in a public or private structure
Disqualifiers
Known diabetes
Concomitant medication that may influence blood sugar (corticosteroids, metformin, GLP1 analogues, SGLT2 inhibitor)
Severe, acute or chronic comorbidity (end-stage renal failure, severe liver disease, heart failure)
Severe anemia
Trial population
Ambulatory patient consulting in primary care in a public or private structure, without patent diabetes
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Fasting blood sugar level
Diagnostic testAssess the level of Blood sugar level in fasting conditions at inclusion
Glycated hemoglobin
Diagnostic testAssess the level of glycated hemoglobin at inclusion
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Prediabetes
Percentage of prediabetic patients discovered at inclusion
Time frame
At inclusionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Dacima Consulting
Lead sponsor
Société Tunisienne de Médecine Générale et de Médecine de Famille
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: